Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity
- 1 May 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (8) , 987-993
- https://doi.org/10.1016/s0959-8049(00)00049-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (09671301, 09470265)
This publication has 19 references indexed in Scilit:
- Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalitiesInternational Journal of Cancer, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancerOncogene, 1998
- First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic EsophagusAnnals of Surgery, 1997
- Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Identification of p53 genetic suppressor elements which confer resistance to cisplatinOncogene, 1997
- Clonal Heterogeneity in Human Esophageal Squamous Cell Carcinomas on DNA AnalysisJapanese Journal of Cancer Research, 1996
- Association of p53 Protein Expression with Responses and Survival of Patients with Locally Advanced Esophageal Carcinoma Treated with ChemoradiotherapyJapanese Journal of Clinical Oncology, 1996
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- p53 Mutations in Human CancersScience, 1991